Jefferies Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Jefferies Group’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-33,100	Closed	-$323K	–	2030
2021 Q4	$323K	Buy	33,100 +13,100	+66%	+$246K	﹤0.01%	1284
2021 Q3	$680K	Sell	20,000 -42,000	-68%	-$1.34M	0.01%	1119
2021 Q2	$2.27M	Buy	62,000 +20,000	+48%	+$774K	0.01%	715
2021 Q1	$1.88M	Buy	42,000 +22,500	+115%	+$1.05M	0.02%	709
2020 Q4	$1.11M	Hold	19,500	–	–	0.01%	907
2020 Q3	$1M	Buy	19,500 +2,900	+17%	+$142K	0.01%	797
2020 Q2	$991	Sell	16,600 -33,300	-67%	-$1.78M	0.01%	759
2020 Q1	$2.05M	Buy	49,900 +19,900	+66%	+$1.1M	0.02%	674
2019 Q4	$1.87M	Buy	+30,000	New	+$1.43M	0.01%	1093

Other funds holding DCPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Jefferies Group's DCPH Position: Q3 2022 in Review

Jefferies Group reduced its Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) stake by 75% in Q3 2022, selling an estimated $8.1M and leaving 175,148 shares worth $3.24M. The position accounts for 0.03% of the portfolio, ranked #458.

Jefferies Group first reported a position in DCPH in Q4 2019 and has held it in 11 quarters since. The position peaked at $9.09M in Q2 2022. 150 funds tracked by Wall St. Rank hold DCPH as of Q3 2022.

Jefferies Group held 175,148 shares of Deciphera Pharmaceuticals, Inc. Common Stock worth $3.24M as of Q3 2022.
Jefferies Group sold 515,852 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q3 2022, an estimated $8.1M.
Deciphera Pharmaceuticals, Inc. Common Stock made up 0.03% of Jefferies Group's portfolio in Q3 2022, its #458 holding.
Jefferies Group first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2019 and has held it in 11 quarters since.
Jefferies Group's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $9.09M in Q2 2022.
150 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.